Get In Touch
Have any questions or comments about the content you see on this page?
Our News
November 8, 2018
We were founded 16 years ago on the belief that we could translate the Nobel Prize-winning discovery of RNA interference (#RNAi) into an entirely new class of medicines with the potential to improve the lives of people living with rare and genetic diseases. Earlier this year, we marked the milestone of our first approved medicine in the U.S. and EU. It hasn’t been an easy journey, but over the years, we’ve been fortunate to the be able to attract many amazing Alnylamites who have said “Challenge Accepted!” and they’ve made our achievements possible.
Have any questions or comments about the content you see on this page?
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site